PMC:7102556 / 15574-15841 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"277","span":{"begin":5,"end":13},"obj":"Species"},{"id":"278","span":{"begin":33,"end":38},"obj":"Species"},{"id":"283","span":{"begin":248,"end":261},"obj":"Disease"}],"attributes":[{"id":"A277","pred":"tao:has_database_id","subj":"277","obj":"Tax:1335626"},{"id":"A278","pred":"tao:has_database_id","subj":"278","obj":"Tax:9606"},{"id":"A283","pred":"tao:has_database_id","subj":"283","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"When MERS-CoV was circulating in human populations in 2012, following similar mechanistic design, Jiang’s research group developed another peptide, designated HR2P, which was derived from the virus HR2 region as well and effectively inhibited MERS-CoV infection [60]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T63","span":{"begin":252,"end":261},"obj":"Disease"}],"attributes":[{"id":"A63","pred":"mondo_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"When MERS-CoV was circulating in human populations in 2012, following similar mechanistic design, Jiang’s research group developed another peptide, designated HR2P, which was derived from the virus HR2 region as well and effectively inhibited MERS-CoV infection [60]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T176","span":{"begin":33,"end":38},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T177","span":{"begin":139,"end":146},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T178","span":{"begin":192,"end":197},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"When MERS-CoV was circulating in human populations in 2012, following similar mechanistic design, Jiang’s research group developed another peptide, designated HR2P, which was derived from the virus HR2 region as well and effectively inhibited MERS-CoV infection [60]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T92","span":{"begin":115,"end":120},"obj":"Chemical"},{"id":"T93","span":{"begin":139,"end":146},"obj":"Chemical"}],"attributes":[{"id":"A92","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A93","pred":"chebi_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"When MERS-CoV was circulating in human populations in 2012, following similar mechanistic design, Jiang’s research group developed another peptide, designated HR2P, which was derived from the virus HR2 region as well and effectively inhibited MERS-CoV infection [60]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T97","span":{"begin":0,"end":267},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"When MERS-CoV was circulating in human populations in 2012, following similar mechanistic design, Jiang’s research group developed another peptide, designated HR2P, which was derived from the virus HR2 region as well and effectively inhibited MERS-CoV infection [60]."}

{"project":"2_test","denotations":[{"id":"32017984-24473083-69697768","span":{"begin":263,"end":265},"obj":"24473083"}],"text":"When MERS-CoV was circulating in human populations in 2012, following similar mechanistic design, Jiang’s research group developed another peptide, designated HR2P, which was derived from the virus HR2 region as well and effectively inhibited MERS-CoV infection [60]."}